These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23708175)

  • 1. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
    Lampert R; Wang Y; Curtis JP
    Am Heart J; 2013 Jun; 165(6):1015-1023.e2. PubMed ID: 23708175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]).
    Dev S; Peterson PN; Wang Y; Curtis JP; Varosy PD; Masoudi FA
    Am J Cardiol; 2014 Jan; 113(2):314-20. PubMed ID: 24216126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD: design and rationale of the EFFORTLESS S-ICD Registry.
    Pedersen SS; Lambiase P; Boersma LV; Murgatroyd F; Johansen JB; Reeve H; Stuart AG; Adragao P; Theuns DA
    Pacing Clin Electrophysiol; 2012 May; 35(5):574-9. PubMed ID: 22360677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study.
    Akar JG; Bao H; Jones P; Wang Y; Chaudhry SI; Varosy P; Masoudi FA; Stein K; Saxon LA; Curtis JP
    Circulation; 2013 Nov; 128(22):2372-83. PubMed ID: 24043302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™.
    Bhatt P; Curtis J; Wang Y; Lampert R
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):861-5. PubMed ID: 22452744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
    Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
    Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician procedure volume and complications of cardioverter-defibrillator implantation.
    Freeman JV; Wang Y; Curtis JP; Heidenreich PA; Hlatky MA
    Circulation; 2012 Jan; 125(1):57-64. PubMed ID: 22095828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
    Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
    Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
    Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in France: practices and regional variability.
    Lazarus A; Biondi N; Thébaut JF; Durand-Zaleski I; Chauvin M
    Europace; 2011 Nov; 13(11):1568-73. PubMed ID: 21784742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.
    Prutkin JM; Reynolds MR; Bao H; Curtis JP; Al-Khatib SM; Aggarwal S; Uslan DZ
    Circulation; 2014 Sep; 130(13):1037-43. PubMed ID: 25081281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.